Outcomes Following Endovascular vs Open Repair of Abdominal Aortic Aneurysm: A Randomized Trial
Lederle FA, Freischlag JA, Kyriakides TC, et al., for the Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group.
JAMA 2009;302:1535-1542.
Open Versus Endovascular Repair (OVER)
Study Question: In the Veterans Affairs (VA) medical centers, what are the short-term (2-year) outcomes following open and endovascular (EVAR) abdominal aortic aneurysm (AAA) repair?
[Ссылки доступны только зарегистрированным пользователям ]
Sex-Specific Trends in Midlife Coronary Heart Disease Risk and Prevalence
Towfighi A, Zheng L, Ovbiagele B.
Arch Intern Med 2009;169:1762-1766.
Study Question: What is the sex-specific midlife prevalence of myocardial infarction (MI) and risk of coronary heart disease (CHD)?
[Ссылки доступны только зарегистрированным пользователям ]
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
The RENAL Replacement Therapy Study Investigators.
N Engl J Med 2009;361:1627-1638.
Study Question: What is the optimal intensity of renal-replacement therapy in patients with acute kidney injury who are critically ill?
[Ссылки доступны только зарегистрированным пользователям ]
High Prevalence of Abnormal Nocturnal Oximetry in Patients With Hypertrophic Cardiomyopathy
Eleid MF, Konecny T, Orgban M, et al.
J Am Coll Cardiol 2009;54:1805-1809.
Study Question: What is the prevalence of nocturnal oxygen desaturation and obstructive sleep apnea (OSA) in a population of patients with hypertrophic cardiomyopathy (HCM)?
[Ссылки доступны только зарегистрированным пользователям ]
Use of Aldosterone Antagonists in Heart Failure
Albert NM, Yancy CW, Liang L, et al.
JAMA 2009;302:1658-1665.
Study Question: How often are aldosterone antagonists prescribed based on heart failure (HF) management guideline criteria and investigator-defined appropriateness criteria, and what are the trends over time in patients hospitalized with HF?
[Ссылки доступны только зарегистрированным пользователям ]
Effects of Liraglutide in the Treatment of Obesity: A Randomised, Double-Blind, Placebo-Controlled Study
Astrup A, Rössner S, Van Gaal L, et al., on behalf of the NN8022-1807 Study Group.
Lancet 2009;Oct 23:[Epub ahead of print].
Study Question: Liraglutide, a glucagon-like peptide-1 (GLP-1) administered subcutaneously once daily, is effective in diabetes and induces weight loss. What is the effect of liraglutide on bodyweight and tolerability in obese individuals without type 2 diabetes?
[Ссылки доступны только зарегистрированным пользователям ]
Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
Holman RR, Farmer AJ, Davies MJ, et al., for the 4-T Study Group.
N Engl J Med 2009;361:1736-1747.
Study Question: What is the relative value of specific insulin regimens superimposed on oral therapy in patients with type 2 diabetes mellitus?
[Ссылки доступны только зарегистрированным пользователям ]
Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force.
Ann Intern Med 2009;151:474-482.
Study Question: Are nontraditional risk factors recommended in screening for coronary heart disease (CHD)?
[Ссылки доступны только зарегистрированным пользователям ]
Reducing Psychosocial Stress: A Novel Mechanism of Improving Survival From Exercise Training
Milani RV, Lavie CJ.
Am J Med 2009;122:931-938.
Study Question: Does reducing psychosocial stress by exercise training improve survival among cardiac patients?
[Ссылки доступны только зарегистрированным пользователям ]
Role of Lifestyle and Aging on the Longitudinal Change in Cardiorespiratory Fitness
Jackson AS, Sui X, Hebert JR, Church TS, Blair SN.
Arch Intern Med 2009;169:1781-1787.
Study Question: What is the impact of lifestyle and aging on longitudinal trends in cardiorespiratory fitness?
[Ссылки доступны только зарегистрированным пользователям ]
|